The senior investigator with the Kaiser Permanente Washington Health Research Institute discusses promising developments from clinical trials on a COVID-19 vaccine under development by Moderna and the National Institutes of Health.
A study published in the New England Journal of Medicine, led by Lisa A. Jackson, MD, of Kaiser Permanente’s Washington Health Research Institute, reports on promising results in the phase 1 trial of an experimental COVID-19 vaccine.
On a recent episode of NPR’s Weekend Edition Saturday, Lisa A. Jackson, MD, an internist with Washington Permanente Medical Group, shared her insights on the race among scientists to develop a vaccine for the new coronavirus that leads to COVID-19 disease.